COVID-19
Conditions
Interventions
kumquat tea group:N/A
Conventional therapy group:N/A
Sponsors
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Those who was positive in SARS-CoV-2 test(i.e. nucleic acid PCR test or antigen test). (2) Patients diagnosed as mild/moderate type according to COVID-19 Diagnosis and Treatment Protocol (Version 9 (3) Patients with Cough.(score of cough evaluation test(CET)>5) (4) Informed consent signed by the patient or their legal representative.
Exclusion criteria
Exclusion criteria: (1) Patients who were allergic to any component of kumquat tea. (2) Those with chronic lung diseases such as bronchiectasis, bronchopneumonia, chronic lung abscess, chronic cough for more than 8 weeks, chronic pharyngitis with cough, lung cancer, respiratory bacterial infections, etc., which affect the judgment of cough symptoms. (3) Heavy smokers (4) Those who are unable to completing follow-up visits. (5) Female subjects during pregnancy (6) Subjects with severe underlying disease or during acute phase of chronic disease, e.g. acute heart failure. (7) Those who have participated or are currently participating in other clinical trials within 1 month prior to this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time from administration of kumquat tea to CET score 5; | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patients whose cough symptoms disappeared on days 3,5 and 7;Disappearance rate of other symptoms on day 3 and 5 after taking kumquat tea. The symptoms include: fever, stuffy or runny nose, sore throat, shortness of breath or difficulty in breathing, fatigue, muscle pain, headache, chills or chills, nausea, number of vomiting, number of diarrhoea, decreased sense of ; | — |
Countries
China
Contacts
Public ContactZhang Zhongde
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed